Search

Your search keyword '"Mittal, Pooja"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Mittal, Pooja" Remove constraint Author: "Mittal, Pooja" Journal journal of clinical oncology Remove constraint Journal: journal of clinical oncology
22 results on '"Mittal, Pooja"'

Search Results

2. Clinical and molecular characterization of FAP and SPP1 in colorectal cancer (CRC), CALGB (Alliance)/SWOG 80405 and real-world data.

4. Impact of expression of metabolic genes on patient (pts) outcomes in metastatic colorectal cancer (mCRC): Data from CALGB/SWOG 80405 (Alliance).

6. Upstream regulation of neurotransmitter signaling genes in metastatic colorectal cancer (mCRC) patients: Data from CALGB/SWOG 80405 trial (Alliance) and MONSTAR-SCREEN-2.

7. Characterization of necroptosis activators in colorectal cancer.

8. Identification and characterization of immunogenic neoantigens in colorectal cancer (CRC).

9. Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).

10. Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).

11. Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.

12. Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

13. LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).

14. Analysis of immune-related genes (IRGs) and their potential role in sexual dimorphism in patients (pts) with metastatic colorectal cancer (mCRC).

16. Molecular correlates of DSCR1 expression in colorectal cancer (CRC).

17. SETD2 gene expression and the molecular landscape of colorectal cancer (CRC).

19. Comprehensive profiling of clock genes expression in hepatocellular carcinoma (HCC).

20. Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.

21. Characterization of MCL-1 in patients with colorectal cancer (CRC): Expression, molecular profiles, and outcomes.

22. Comprehensive characterization of androgen receptor expression in breast cancer.

Catalog

Books, media, physical & digital resources